These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35469679)
21. Identification and early anticoagulation in patients with atrial fibrillation in the emergency department. Schwab K; Smith R; Wager E; Kaur S; Alvarez L; Wagner J; Leung H Am J Emerg Med; 2021 Jun; 44():315-322. PubMed ID: 32331958 [TBL] [Abstract][Full Text] [Related]
22. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter. Miller RJH; Chew DS; Rezazadeh S; Klassen S; Pournazari P; Lang E; Quinn FR Can J Cardiol; 2018 Jun; 34(6):804-807. PubMed ID: 29801744 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Halperin JL; Hankey GJ; Wojdyla DM; Piccini JP; Lokhnygina Y; Patel MR; Breithardt G; Singer DE; Becker RC; Hacke W; Paolini JF; Nessel CC; Mahaffey KW; Califf RM; Fox KA; Circulation; 2014 Jul; 130(2):138-46. PubMed ID: 24895454 [TBL] [Abstract][Full Text] [Related]
24. Effects of a reminder to initiate oral anticoagulation in patients with atrial fibrillation/atrial flutter discharged from the emergency department: REMINDER study. Rezazadeh S; Chew DS; Miller RJH; Klassen S; Pournazari P; Bennett G; Lang E; Quinn FR CJEM; 2018 Nov; 20(6):841-849. PubMed ID: 30295590 [TBL] [Abstract][Full Text] [Related]
25. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation. Graham DJ; Baro E; Zhang R; Liao J; Wernecke M; Reichman ME; Hu M; Illoh O; Wei Y; Goulding MR; Chillarige Y; Southworth MR; MaCurdy TE; Kelman JA Am J Med; 2019 May; 132(5):596-604.e11. PubMed ID: 30639551 [TBL] [Abstract][Full Text] [Related]
26. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control. Janzic A; Kos M Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096 [TBL] [Abstract][Full Text] [Related]
27. The Use of Oral Anticoagulants in Patients with Atrial Fibrillation in the Emergency Department. Hua H; Sur N; Choi J; Polineni S; Lee L; Chaturvedi S J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104599. PubMed ID: 32001107 [TBL] [Abstract][Full Text] [Related]
28. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Coleman CI; Peacock WF; Bunz TJ; Alberts MJ Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814 [TBL] [Abstract][Full Text] [Related]
29. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention. Hirano T; Kaneko H; Mishina S; Wang F; Morita S J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651 [TBL] [Abstract][Full Text] [Related]
30. Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation. Atzema CL; Jackevicius CA; Chong A; Dorian P; Ivers NM; Parkash R; Austin PC CMAJ; 2019 Dec; 191(49):E1345-E1354. PubMed ID: 31818927 [TBL] [Abstract][Full Text] [Related]
31. Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study. Van Ganse E; Danchin N; Mahé I; Hanon O; Jacoud F; Nolin M; Dalon F; Lefevre C; Cotté FE; Gollety S; Falissard B; Belhassen M; Steg PG Stroke; 2020 Jul; 51(7):2066-2075. PubMed ID: 32539675 [TBL] [Abstract][Full Text] [Related]
32. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China. Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y; Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643 [TBL] [Abstract][Full Text] [Related]
33. Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin. Senoo K; Lip GY Stroke; 2016 Jun; 47(6):1665-8. PubMed ID: 27125527 [TBL] [Abstract][Full Text] [Related]
34. Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events. Zubaid M; Rashed WA; Alsheikh-Ali AA; Al-Zakwani I; AlMahmeed W; Shehab A; Sulaiman K; Qudaimi AA; Asaad N; Amin H; Angiology; 2015 May; 66(5):464-71. PubMed ID: 24904179 [TBL] [Abstract][Full Text] [Related]
35. Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. Pokorney SD; Piccini JP; Stevens SR; Patel MR; Pieper KS; Halperin JL; Breithardt G; Singer DE; Hankey GJ; Hacke W; Becker RC; Berkowitz SD; Nessel CC; Mahaffey KW; Fox KA; Califf RM; ; J Am Heart Assoc; 2016 Mar; 5(3):e002197. PubMed ID: 26955859 [TBL] [Abstract][Full Text] [Related]
36. Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation. Hua H; Sur N; Lee L; Chaturvedi S J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105474. PubMed ID: 33242786 [TBL] [Abstract][Full Text] [Related]
37. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196 [TBL] [Abstract][Full Text] [Related]
38. Geographic and temporal variation in the treatment and outcomes of atrial fibrillation: a population-based analysis of national quality indicators. Chew DS; Au F; Xu Y; Manns BJ; Tonelli M; Wilton SB; Hemmelgarn B; Kong S; Exner DV; Quinn AE CMAJ Open; 2022; 10(3):E702-E713. PubMed ID: 35918151 [TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry. O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448 [TBL] [Abstract][Full Text] [Related]
40. Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Briceno DF; Villablanca P; Cyrille N; Massera D; Bader E; Manheimer E; Aagaard P; Ferrick K; Gross J; Kim SG; Krumerman A; Palma E; Guttenplan N; Romero J; Fisher J; Garcia M; Natale A; Di Biase L Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1057-64. PubMed ID: 26226997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]